Total Visits

Views
A personalized medicine ex vivo test to predict clinical response to first line induction therapy with idarubicin and cytarabine in patients with acute myeloid leukemia11

Select a period of time:

Views

Views
October 20241
November 20240
December 20240
January 20250
February 20251
March 20250
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States1
 

Top cities views

Views